Home
About
Overview
Sharing Data
ORCID
Help
History (1)
DNA Double-strand Break Signaling Is a Therapeutic Target in Head and Neck Cancer.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
DNA Double-strand Break Signaling Is a Therapeutic Target in Head and Neck Cancer.
DNA Double-strand Break Signaling Is a Therapeutic Target in Head and Neck Cancer. Anticancer Res. 2021 Nov; 41(11):5393-5403.
View in:
PubMed
subject areas
Animals
Antineoplastic Agents
Apoptosis
Ataxia Telangiectasia Mutated Proteins
Cell Cycle Proteins
Cell Line, Tumor
Cell Proliferation
DNA Breaks, Double-Stranded
Female
G2 Phase Cell Cycle Checkpoints
Head and Neck Neoplasms
Humans
Male
Mice
Mice, Nude
Protein Kinase Inhibitors
Signal Transduction
Tumor Burden
Tumor Suppressor p53-Binding Protein 1
Xenograft Model Antitumor Assays
authors with profiles
Ardaman Shergill